| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $349.00K | $3.15M | $24.11M | $31.01M | $52.42M |
| SG&A | $5.69M | $11.00M | $22.84M | $20.21M | $20.95M |
| Operating Income | -$2.54M | -$20.16M | -$49.26M | -$51.23M | -$73.37M |
| Interest Expense | $0.00 | $0.00 | $11.41M | $11.57M | $7.19M |
| Tax Expense | $0.00 | -$203.00K | $0.00 | $70.00K | $0.00 |
| Net Income | $149.05M | -$18.96M | -$59.08M | -$62.22M | -$80.53M |
| EPS (basic) | 0.6400 | -0.3400 | – | – | – |
| EPS (diluted) | 0.6400 | -0.3400 | – | – | – |
| Shares (diluted) | $98.50M | $54.63M | – | – | – |